Cargando…
Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide with high mortality. Circulating miRNA has been demonstrated as a novel noninvasive biomarker for many tumors. This study aimed to investigate the potential of circulating miR-125b as a prognostic marker of HCC. Exosomes were e...
Autores principales: | Liu, Weifeng, Hu, Jie, Zhou, Kaiqian, Chen, Feiyu, Wang, Zheng, Liao, Boyi, Dai, Zhi, Cao, Ya, Fan, Jia, Zhou, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546809/ https://www.ncbi.nlm.nih.gov/pubmed/28814883 http://dx.doi.org/10.2147/OTT.S140062 |
Ejemplares similares
-
IFN-γ promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b
por: Yang, Ruili, et al.
Publicado: (2020) -
Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma
por: Zhang, Xiangyu, et al.
Publicado: (2022) -
Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer
por: Su, Ying Ying, et al.
Publicado: (2019) -
Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma
por: Sun, Li, et al.
Publicado: (2021) -
Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma
por: Chen, Shuying, et al.
Publicado: (2022)